| Literature DB >> 30933483 |
Zhengying Gu1, Tianqing Liu2, Jie Tang1, Yannan Yang1, Hao Song1, Zewen K Tuong3, Jianye Fu1, Chengzhong Yu1,4.
Abstract
Iron oxide nanoparticles (IONPs) have emerging anticancer applications via polarizing tumor-associated macrophages from tumor-promoting phenotype (M2) to tumor-suppressing phenotype (M1). However, the underlying mechanism and structure-function relationship remain unclear. We report magnetite IONPs are more effective compared to hematite in M1 polarization and tumor suppression. Moreover, magnetite IONPs specifically rely on interferon regulatory factor 5 signaling pathway for M1 polarization and down-regulate M2-assoicated arginase-1. This study provides new understandings and paves the way for designing advanced iron-based anticancer technologies.Entities:
Year: 2019 PMID: 30933483 DOI: 10.1021/jacs.8b10904
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419